August 22, 2020 - Issue: Vol. 166, No. 149 — Daily Edition116th Congress (2019 - 2020) - 2nd Session

[Page H4300]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]




                     EXECUTIVE COMMUNICATIONS, ETC.

   Under clause 2 of rule XIV, executive communications were taken from 
the Speaker's table and referred as follows:

       5072. A letter from the Assistant General Counsel for 
     Regulatory Affairs, Pension Benefit Guaranty Corporation, 
     transmitting the Corporation's final rule -- Benefits Payable 
     in Terminated Single-Employer Plans; Interest Assumptions for 
     Paying Benefits; received July 23, 2020, pursuant to 5 U.S.C. 
     801(a)(1)(A); Public Law 104-121, Sec. 251; (110 Stat. 868); 
     to the Committee on Education and Labor.
       5073. A letter from the Director, Regulations Policy and 
     Management Staff, Food and Drug Administration, Department of 
     Health and Human Services, transmitting the Department's 
     final rule -- Medical Devices; Exemption From Premarket 
     Notification: Class II Devices [Docket No.: FDA-2019-N-2686] 
     received July 23, 2020, pursuant to 5 U.S.C. 801(a)(1)(A); 
     Public Law 104-121, Sec. 251; (110 Stat. 868); to the 
     Committee on Energy and Commerce.
       5074. A letter from the Director, Regulations Policy and 
     Management Staff, Food and Drug Administration, Department of 
     Health and Human Services, transmitting the Department's 
     final rule -- Medical Devices; Petitions for an 
     Administrative Stay of Action: Electrical Stimulation Devices 
     for Self- Injurious or Aggressive Behavior [Docket No.: FDA-
     2016-N-1111] received July 23, 2020, pursuant to 5 U.S.C. 
     801(a)(1)(A); Public Law 104-121, Sec. 251; (110 Stat. 868); 
     to the Committee on Energy and Commerce.

                          ____________________